Correlation of E-cadherin expression with clinicopathological data in patients suffering from transitional cell carcinoma of the bladder

被引:0
|
作者
Charalabopoulos, K [1 ]
Tsambalas, S
Syrigos, K
Giannakopoulos, X
Kalfakakou, V
Kiortsis, D
Alamanos, J
Charalabopoulos, A
Evangelou, A
Sofikitis, N
Agnantis, NJ
机构
[1] Univ Ioannina, Fac Med, Dept Physiol, Clin Unit, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Fac Med, Dept Epidemiol Stat, GR-45110 Ioannina, Greece
[3] Univ Ioannina, Fac Med, Dept Pathol, GR-45110 Ioannina, Greece
[4] Univ Athens, Fac Med, Dept Med 3, Oncol Immunol Unit, Athens, Greece
[5] Univ Ioannina, Fac Med, Dept Urol, GR-45110 Ioannina, Greece
来源
EXPERIMENTAL ONCOLOGY | 2003年 / 25卷 / 03期
关键词
bladder cancer; transitional cell carcinoma; E-cadherin; adhesion molecules; invasion; metastasis; differentiation;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial cadherin (E-cadherin, E-cad) is a calcium-dependent cell-cell adhesion molecule that binds cells through homotypic fashion interactions. Its role is crucial in the induction and maintenance of cell polarity and differentiation. Downregulation or loss of its function is associated with an invasive and aggressive phenotype in many types of human cancers. 45 male patients (mean age 63 years, age range from 29 years to 87 years) with transitional cell carcinoma (TCC) of the bladder were included in the study. E-cad expression was estimated immunohistochemically in a semiquantitative fashion using light microscopy. An avidin-biotin immunoperoxidase technique was employed using anti E-cad murine monoclonal antibodies. Loss of the E-cad normal surface expression by the bladder cells was found in 32/45 (71%) of patients compared to normal bladder epithelia observed at the intercellular borders (p<0.001). A statistically significant difference between abnormal expression of E-cad and tumor grade and disease stage was also observed (p<0.001). Loss of the surface E-cadherin expression was most frequently detected in grade 3 bladder cancer patients (17/21, 80.95%) than in well differentiated tumors (grade 1) (3/7, 43.86%) (p<0.001). Surface E-cadherin expression was also most frequently lost in bladder cancer patients with lymph node and distant organs metastases (stage 4) (1/1,100%) compared to 13/25 (52%) of patients with lymph node-negative tumors (stage 1) (p<0.001). We conclude that E-cad adhesion molecule is a useful marker and the loss of its expression is associated with high grade and advanced stage in patients suffering from TCC of the bladder.
引用
收藏
页码:180 / 185
页数:6
相关论文
共 50 条
  • [1] E-Cadherin Tissue Expression and Urinary Soluble Forms of E-Cadherin in Patients with Bladder Transitional Cell Carcinoma
    Shi, Benkang
    Laudon, Vincent
    Yu, Shengqiang
    Dong, Dexin
    Zhu, Yaofeng
    Xu, Zhishun
    UROLOGIA INTERNATIONALIS, 2008, 81 (03) : 320 - 324
  • [2] Correlation of E-cadherin expression with clinicopathological parameters in breast carcinoma
    Cobanoglu, U
    Ersoz, S
    Turgutalp, H
    Reis, A
    Ozoran, Y
    SAUDI MEDICAL JOURNAL, 2004, 25 (08) : 1024 - 1027
  • [3] p130Cas, E-cadherin and β-catenin in human transitional cell carcinoma of the bladder: Expression and clinicopathological significance
    Hu, Xiangkun
    Ruan, Yuan
    Cheng, Fan
    Yu, Weimin
    Zhang, Xiaobin
    Larre, Stephane
    INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (09) : 630 - 637
  • [4] E-CADHERIN EXPRESSION IN PAPILLARY TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER
    ROSS, JS
    DELROSARIO, AD
    FIGGE, HL
    SHEEHAN, C
    FISHER, HAG
    BUI, HX
    HUMAN PATHOLOGY, 1995, 26 (09) : 940 - 944
  • [5] Characteristics of bladder transitional cell carcinoma with E-cadherin and N-cadherin double-negative expression
    Luo, Yang
    Zhu, Yong-Tong
    Ma, Li-Li
    Pang, Shi-Yu
    Wei, Li-Jie
    Lei, Cheng-Yong
    He, Cheng-Wu
    Tan, Wan-Long
    ONCOLOGY LETTERS, 2016, 12 (01) : 530 - 536
  • [6] E-Cadherin Expression as a Prognostic Factor in Transitional Cell Carcinoma of The Bladder After Transurethral Resection
    Khorrami, Mohammad Hatef
    Hadi, Mazaher
    Gharaati, Mohammad Reza
    Izadpanahi, Mohammad Hossein
    Javid, Amir
    Zargham, Mahtab
    UROLOGY JOURNAL, 2012, 9 (03) : 581 - 585
  • [7] The significance of E-cadherin in transitional-cell carcinoma of the human urinary bladder
    Fujisawa, M
    Miyazaki, J
    Takechi, Y
    Arakawa, S
    WORLD JOURNAL OF UROLOGY, 1996, 14 : S12 - S15
  • [8] E-cadherin expression in transitional cell carcinomas
    Szekely, Eszter
    Torok, Virag
    Szekely, Tamas
    Riesz, Peter
    Romics, Imre
    PATHOLOGY & ONCOLOGY RESEARCH, 2006, 12 (02) : 73 - 77
  • [9] Expression of E-cadherin/catenin complex in nasopharyngeal carcinoma: Correlation with clinicopathological parameters
    Lou, PJ
    Chen, WP
    Sheen, TS
    Ko, JY
    Hsu, MM
    Wu, JC
    ONCOLOGY REPORTS, 1999, 6 (05) : 1065 - 1071
  • [10] The Prognostic Importance of E-cadherin and p53 Gene Expression in Transitional Bladder Carcinoma Patients
    Arisan Serdar
    Caskurlu Turhan
    Guney Soner
    Sonmez Nurettin Cem
    Keles Bayram
    Buyuktuncer Elif Damla
    Ergenekon Erbil
    International Urology and Nephrology, 2005, 37 : 485 - 492